← Back to Search

Feedback on RTD metric for Antibiotics

N/A
Recruiting
Research Sponsored by Daniel Livorsi
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Any clinician who works in Urgent Care or QuickCare clinics within our healthcare system
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days
Awards & highlights

Study Summary

"This trial will see if giving feedback to doctors about how often they prescribe antibiotics for respiratory infections compared to their peers can help reduce unnecessary antibiotic use in patients with acute respiratory infections. The study will take place

Who is the study for?
This trial is for clinicians working in Urgent Care or QuickCare clinics within a specific healthcare system. It aims to evaluate their antibiotic prescribing habits for acute respiratory infections.Check my eligibility
What is being tested?
The study tests whether giving clinicians feedback on their antibiotic prescription rates, compared to their peers, can reduce unnecessary prescriptions for viral respiratory infections.See study design
What are the potential side effects?
Since this trial involves providing feedback rather than medical interventions, there are no direct side effects related to medications or treatments.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Frequency of antibiotic-prescribing for RTD visits
Secondary outcome measures
Follow-up Emergency Department visit and/or acute-care hospitalization
Follow-up visit to Urgent Care or QuickCare
Frequency of antibiotic-prescribing for all visits

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Feedback on RTD metricExperimental Treatment1 Intervention
An e-mail will be sent to the clinicians in the experimental arm every two months describing their performance on the RTD metric and making a comparison to how their peers have performed. The e-mail will also direct clinicians to visit a dashboard to review their practice in greater depth.
Group II: No feedback on RTD metricActive Control1 Intervention
Any clinician assigned to the control arm will not receive the above-mentioned e-mails.

Find a Location

Who is running the clinical trial?

Daniel LivorsiLead Sponsor

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the overall count of participants joining this research investigation?

"Affirmative. The details available on clinicaltrials.gov show that this medical investigation is presently in search of potential participants. Originally uploaded on January 1st, 2024, the latest update was done on March 29th, 2024. This trial aims to recruit a total of 90 individuals at one specific site."

Answered by AI

Does this study include individuals older than fifty years of age as participants?

"This research is open to individuals aged over 21 years and under the age of 99."

Answered by AI

Are there any available slots for patients to participate in this research study?

"Indeed, as per clinicaltrials.gov, this investigation is presently enrolling participants. The trial was initially published on January 1st, 2024 and last revised on March 29th, 2024. They aim to recruit a total of 90 individuals from one designated site."

Answered by AI
~60 spots leftby Jun 2025